ImmunoGen
IMGN
#2156
Rank
NZ$15.26 B
Marketcap
NZ$54.66
Share price
0.00%
Change (1 day)
137.08%
Change (1 year)

Earnings for ImmunoGen (IMGN)

Earnings in 2023 (TTM): -NZ$96.61 Million

According to ImmunoGen 's latest financial reports the company's current earnings are NZ$0.28 Billion. In 2022 the company made an earning of -NZ$0.39 Billion a decrease over its 2021 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoGen from 1989 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$96.61 Million-74.63%
2022 -NZ$0.39 Billion72.45%
2021 -NZ$0.23 Billion495.9%
2020 -NZ$37.05 Million-75.71%
2019 -NZ$0.16 Billion-44.88%
2018 -NZ$0.28 Billion99.42%
2017 -NZ$0.14 Billion
2015 -NZ$0.19 Billion43.7%
2014 -NZ$0.13 Billion135.39%
2013 -NZ$53.98 Million-66.03%
2012 -NZ$0.16 Billion42.86%
2011 -NZ$0.12 Billion16.68%
2010 -NZ$95.31 Million32.83%
2009 -NZ$71.76 Million-1.99%
2008 -NZ$73.22 Million108.61%
2007 -NZ$35.1 Million-10.13%
2006 -NZ$39.06 Million28.86%
2005 -NZ$30.31 Million120.33%
2004 -NZ$13.76 Million-61.19%
2003 -NZ$35.44 Million-16.6%
2002 -NZ$42.5 Million51.86%
2001 -NZ$27.99 Million
1999 NZ$1.57 M-112.68%
1998 -NZ$12.43 Million-13.41%
1997 -NZ$14.36 Million-10.87%
1996 -NZ$16.11 Million-35.66%
1995 -NZ$25.03 Million-19.21%
1994 -NZ$30.98 Million-14.49%
1993 -NZ$36.23 Million23.95%
1992 -NZ$29.23 Million
1989 -NZ$12.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.71 B-53,544.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.61 B-26,146.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.83 B-16,334.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$45.03 B-41,086.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.70 B-14,397.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.47 B-12,364.13%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$16.32 B-14,958.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.39 Billion 1,159.30%๐Ÿ‡บ๐Ÿ‡ธ USA